Monopar Therapeutics (MNPR) Stock Chart & Stock Price History → [URGENT] DO NOT Touch These AI Stocks! (From Weiss Ratings) (Ad) Free MNPR Stock Alerts $0.60 -0.05 (-7.71%) (As of 05/15/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Monopar Therapeutics Stock Price Performance5 Day Performance-3.29%1 Month Performance-14.46%3 Month Performance+91.15%6 Month Performance+96.88%Year-To-Date Performance+91.09%1 Year Performance-24.41% Receive MNPR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Monopar Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Weiss RatingsHow to Play the AI and Crypto Markets in One SwingI’ve developed a system that’s helped me find huge winners in the past. Now my system has alerted me to the next four altcoins that could be the next superstars.Click here to find out who they are. MNPR Stock Chart for Wednesday, May, 15, 2024 MNPR Chart by TradingView Monopar Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/14/2024$0.68$0.65-3.57%$0.71$0.6562,569 shs$11.38 million05/13/2024$0.67$0.68+0.43%$0.74$0.6823,987 shs$11.80 million05/10/2024$0.71$0.67-5.47%$0.75$0.63130,716 shs$11.73 million05/09/2024$0.75$0.71-5.19%$0.80$0.7149,375 shs$12.41 million05/08/2024$0.76$0.75-1.57%$0.77$0.7412,691 shs$13.09 million05/07/2024$0.79$0.76-3.79%$0.82$0.7618,376 shs$13.30 million Get the Latest News and Ratings for MNPR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Monopar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/06/2024$0.73$0.79+8.91%$0.80$0.7081,539 shs$13.82 million05/03/2024$0.65$0.73+11.71%$0.76$0.64129,520 shs$12.69 million05/02/2024$0.65$0.65+0.15%$0.67$0.6431,935 shs$11.36 million05/01/2024$0.66$0.65-1.53%$0.68$0.6419,630 shs$11.34 million04/30/2024$0.65$0.66+1.55%$0.69$0.6354,623 shs$11.52 million04/29/2024$0.66$0.65-1.25%$0.68$0.6414,989 shs$11.34 million04/26/2024$0.63$0.66+4.89%$0.67$0.6334,406 shs$11.49 million04/25/2024$0.66$0.63-4.49%$0.65$0.6258,239 shs$10.95 million04/24/2024$0.65$0.66+1.08%$0.68$0.6439,446 shs$11.47 million04/23/2024$0.63$0.65+2.85%$0.66$0.6285,749 shs$11.34 million04/22/2024$0.64$0.63-1.27%$0.66$0.6227,592 shs$11.03 million04/19/2024$0.68$0.64-5.59%$0.68$0.6233,081 shs$11.17 million04/18/2024$0.65$0.68+4.31%$0.72$0.6677,544 shs$11.83 million04/17/2024$0.73$0.65-10.71%$0.72$0.65150,308 shs$11.34 million04/16/2024$0.76$0.73-4.21%$0.74$0.69178,622 shs$12.71 million04/15/2024$0.78$0.76-2.69%$0.78$0.75101,444 shs$13.26 million04/12/2024$0.77$0.78+1.43%$0.82$0.76280,338 shs$13.63 million04/11/2024$0.61$0.77+25.82%$0.85$0.72844,911 shs$13.44 million04/10/2024$0.59$0.61+3.62%$0.65$0.50457,382 shs$10.68 million04/09/2024$0.60$0.59-1.73%$0.63$0.5896,424 shs$10.31 million04/08/2024$0.60$0.60-0.17%$0.63$0.58149,863 shs$10.49 million04/05/2024$0.64$0.60-5.70%$0.64$0.60128,398 shs$10.51 million04/04/2024$0.64$0.64-0.56%$0.68$0.62137,827 shs$11.14 million04/03/2024$0.64$0.64+0.31%$0.64$0.56164,643 shs$11.20 million04/02/2024$0.66$0.64-3.06%$0.69$0.6399,684 shs$9.52 million04/01/2024$0.68$0.66-3.05%$0.71$0.64102,698 shs$9.82 million03/29/2024$0.68$0.68$0.73$0.64290,922 shs$10.13 million03/28/2024$0.74$0.68-7.60%$0.73$0.64290,144 shs$10.13 million03/27/2024$0.74$0.74+0.10%$0.80$0.70142,611 shs$10.96 million03/26/2024$0.71$0.74+3.70%$0.79$0.67104,034 shs$10.95 million03/25/2024$0.69$0.71+2.96%$0.71$0.6660,043 shs$10.56 million03/22/2024$0.70$0.69-1.50%$0.70$0.63187,818 shs$10.25 million03/21/2024$0.77$0.70-8.75%$0.78$0.69214,141 shs$10.41 million03/20/2024$0.76$0.77+0.76%$0.77$0.70131,305 shs$11.41 millionWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radar (Ad)Revolutionizing communication is what this NASDAQ-traded next-gen solution provider is doing. See how this company is well-positioned to capitalize in 202403/19/2024$0.67$0.76+13.64%$0.86$0.74947,088 shs$11.32 million03/18/2024$0.65$0.67+2.92%$0.72$0.65251,771 shs$9.96 million03/15/2024$0.71$0.65-8.31%$0.76$0.65265,251 shs$9.68 million03/14/2024$0.75$0.71-5.60%$0.78$0.71142,102 shs$10.56 million03/13/2024$0.83$0.75-8.95%$0.80$0.71302,329 shs$11.18 million03/12/2024$0.91$0.83-9.39%$0.90$0.81145,577 shs$12.28 million03/11/2024$0.82$0.91+11.63%$0.93$0.84200,668 shs$13.56 million03/08/2024$0.91$0.82-10.62%$0.92$0.73670,392 shs$12.14 million03/07/2024$0.96$0.91-4.83%$0.98$0.90298,014 shs$13.59 million03/06/2024$1.06$0.96-9.43%$1.06$0.88654,415 shs$14.28 million03/05/2024$0.99$1.06+7.06%$1.20$1.031.64 million shs$15.76 million03/04/2024$0.90$0.99+10.51%$1.13$0.82901,839 shs$14.72 million03/01/2024$0.83$0.90+7.94%$0.95$0.741.11 million shs$13.32 million02/29/2024$1.00$0.83-17.00%$1.05$0.701.34 million shs$12.34 million02/28/2024$1.21$1.00-17.36%$1.19$0.961.51 million shs$14.87 million02/27/2024$1.35$1.21-10.37%$1.32$1.121.57 million shs$17.99 million02/26/2024$1.30$1.35+3.85%$1.48$1.006.87 million shs$20.07 million02/23/2024$1.12$1.30+16.07%$1.73$1.1861.04 million shs$19.33 million02/22/2024$0.57$1.12+96.49%$1.37$0.73153.05 million shs$16.65 million02/21/2024$0.67$0.57-14.80%$0.63$0.512.37 million shs$8.48 million02/20/2024$0.34$0.67+95.27%$1.56$0.60100.05 million shs$9.95 million02/19/2024$0.34$0.34$0.35$0.3423,500 shs$5.09 million02/16/2024$0.34$0.34+0.74%$0.35$0.3413,581 shs$5.09 million02/15/2024$0.34$0.34+0.80%$0.36$0.3356,181 shs$5.06 million02/14/2024$0.33$0.34+2.21%$0.34$0.3335,672 shs$5.02 million Related Companies: Kiora Pharmaceuticals Stock Price Chart RedHill Biopharma Stock Price Chart Avalo Therapeutics Stock Price Chart Pieris Pharmaceuticals Stock Price Chart Purple Biotech Stock Price Chart Imunon Stock Price Chart FSD Pharma Stock Price Chart Edesa Biotech Stock Price Chart Elevai Labs Stock Price Chart Akari Therapeutics Stock Price Chart Receive MNPR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Monopar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MNPR) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersAmazon's betting big on this unknown AI companyManward PressWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking $16T Elon Musk Crypto LeakCrypto 101 MediaDems have chosen Biden replacement?Paradigm PressGold Set to EXPLODE!Gold Safe ExchangeThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss Ratings"The Biggest Drug Ever" Is ComingBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Monopar Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.